PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
21.86%
Positive growth while JHX shows revenue decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
21.86%
Positive growth while JHX shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.86%
EBITDA growth below 50% of JHX's 139.32%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
21.86%
Operating income growth below 50% of JHX's 123.19%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Other expenses growth while JHX reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-169.74%
Tax expense reduction while JHX shows 78.29% growth. Joel Greenblatt would examine advantage.
169.74%
Net income growth exceeding 1.5x JHX's 43.58%. David Dodd would verify competitive advantages.
121.36%
Net margin growth exceeding 1.5x JHX's 55.00%. David Dodd would verify competitive advantages.
160.00%
EPS growth exceeding 1.5x JHX's 50.00%. David Dodd would verify competitive advantages.
160.00%
Diluted EPS growth exceeding 1.5x JHX's 51.06%. David Dodd would verify competitive advantages.
3.74%
Share count increase while JHX reduces shares. John Neff would investigate differences.
3.74%
Diluted share reduction below 50% of JHX's 0.12%. Michael Burry would check for concerns.